Stereotaxis Statistics
Total Valuation
Stereotaxis has a market cap or net worth of $145.45 million. The enterprise value is $132.59 million.
| Market Cap | 145.45M |
| Enterprise Value | 132.59M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stereotaxis has 82.64 million shares outstanding. The number of shares has increased by 9.12% in one year.
| Shares Outstanding | 82.64M |
| Shares Change (YoY) | +9.12% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 15.78% |
| Owned by Institutions (%) | 51.08% |
| Float | 55.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.37 |
| Forward PS | 4.31 |
| PB Ratio | 9.99 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.43 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -119.50% and return on invested capital (ROIC) is -105.07%.
| Return on Equity (ROE) | -119.50% |
| Return on Assets (ROA) | -48.70% |
| Return on Capital (ROIC) | -105.07% |
| Revenue Per Employee | $222,156 |
| Profits Per Employee | -$173,902 |
| Employee Count | 122 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.29% in the last 52 weeks. The beta is 1.53, so Stereotaxis's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +14.29% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 34.83 |
| Average Volume (20 Days) | 576,151 |
Short Selling Information
The latest short interest is 1.28 million, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 1.28M |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 1.55% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 4.25 |
Income Statement
In the last 12 months, Stereotaxis had revenue of $27.10 million and -$21.22 million in losses. Loss per share was -$0.26.
| Revenue | 27.10M |
| Gross Profit | 14.95M |
| Operating Income | -20.97M |
| Pretax Income | -19.87M |
| Net Income | -21.22M |
| EBITDA | -19.27M |
| EBIT | -19.87M |
| Loss Per Share | -$0.26 |
Balance Sheet
The company has $18.25 million in cash and $5.39 million in debt, giving a net cash position of $12.86 million or $0.16 per share.
| Cash & Cash Equivalents | 18.25M |
| Total Debt | 5.39M |
| Net Cash | 12.86M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 14.57M |
| Book Value Per Share | 0.18 |
| Working Capital | 18.36M |
Cash Flow
In the last 12 months, operating cash flow was -$8.68 million and capital expenditures -$17,000, giving a free cash flow of -$8.70 million.
| Operating Cash Flow | -8.68M |
| Capital Expenditures | -17,000 |
| Free Cash Flow | -8.70M |
| FCF Per Share | -$0.10 |
Margins
Gross margin is 55.16%, with operating and profit margins of -77.36% and -78.28%.
| Gross Margin | 55.16% |
| Operating Margin | -77.36% |
| Pretax Margin | -73.32% |
| Profit Margin | -78.28% |
| EBITDA Margin | -71.10% |
| EBIT Margin | -73.32% |
| FCF Margin | -32.10% |
Dividends & Yields
Stereotaxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.12% |
| Shareholder Yield | -9.12% |
| Earnings Yield | -14.59% |
| FCF Yield | -5.98% |
Analyst Forecast
The average price target for Stereotaxis is $4.50, which is 155.68% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 155.68% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 4, 2013. It was a forward split with a ratio of 1096:1000.
| Last Split Date | Nov 4, 2013 |
| Split Type | Forward |
| Split Ratio | 1096:1000 |
Scores
Stereotaxis has an Altman Z-Score of -15.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.16 |
| Piotroski F-Score | 3 |